KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Non Operating Investment Income (2022 - 2024)

Clover Health Investments' Non Operating Investment Income history spans 3 years, with the latest figure at -$467000.0 for Q1 2024.

  • For Q1 2024, Non Operating Investment Income changed N/A year-over-year to -$467000.0; the TTM value through Dec 2024 reached -$467000.0, up 90.12%, while the annual FY2024 figure was -$467000.0, 90.12% up from the prior year.
  • Non Operating Investment Income reached -$467000.0 in Q1 2024 per CLOV's latest filing, up from -$4.7 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $12.4 million in Q1 2022 to a low of -$4.7 million in Q4 2023.
  • Average Non Operating Investment Income over 3 years is $670666.7, with a median of -$975000.0 recorded in 2022.
  • The largest YoY upside for Non Operating Investment Income was 387.22% in 2023 against a maximum downside of 387.22% in 2023.
  • A 3-year view of Non Operating Investment Income shows it stood at -$970000.0 in 2022, then crashed by 387.22% to -$4.7 million in 2023, then skyrocketed by 90.12% to -$467000.0 in 2024.
  • Per Business Quant, the three most recent readings for CLOV's Non Operating Investment Income are -$467000.0 (Q1 2024), -$4.7 million (Q4 2023), and -$970000.0 (Q4 2022).